The CC lacked the "go-get-em" spirit and lack-lustre in regard to what is next, the mantra was lets take it slow, lets make sure we get it right, lets stay in the US market
- Clinical indication: only CD was mentioned and there it was a slow release, lets do a prevU with the 1000 or so injectors in the USA once we have the approval and then lets slowly find out how much to use and maybe we can then learn something for the next indications. There was no clear plan on which indications to do next, we all know how long this takes and if you have NO plan now, there will be NO sales forthcoming for the next 2 plus years.
- Europe and other markets: again no plan or vision at all. Almost vertbatim it was "Lets do USA first and then we will see" Again EMA and China FDA take just as long and if you do not start now - nothing will be on the books in regard to sales in the next two years.
In all, no vison and no agressive expansion plans.